The separation will be a smooth one that will not affect patients or company services.
MIAMI, Fla. (PRWEB) September 22, 2015
Global Stem Cells Group and Regenestem / Regenestem Network have announced that, due to explosive growth and internal restructuring, they will be separating into two independent companies as of Sept. 21, 2015. Regenestem founder, president and CEO Ricardo De Cubas says the move will help the stem cell research and treatment pioneers’ ability to serve clients by operating as two independent companies.
Regenestem has operated as a division of Global Stem Cells Group since 2012, with Regenestem Network joining GSCG in 2014. In just three years, the Global Stem Cells Group grew into one of the world’s premier providers of regenerative medicine, research and education opportunities.
De Cubas will head the newly independent Regenestem and Regenestem Network. Benito Novas, president and CEO of Global Stem cells Group, will head the GSCG brand independently.
Both DeCubas and Novas say the separation will be a smooth one that will not affect patients or company services.
Under the direction of Global Stem Cells Group, Regenestem expanded its clinical presence and partnered with qualified physicians experienced in stem cell therapies to open new clinics worldwide. In 2014, the Regenestem Network’s presence was expanded to include 20 countries with new, state-of-the-art regenerative medicine facilities offering a variety of stem cell treatments to help patients with a variety of diseases and conditions including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, and pain, attracting patients from the United States and around the world. Regenestem clinics provide services in more than 10 specialties.
Both Global Stem Cells Group and Regenestem will remain certified for the medical tourism market, and continue to operate with staff physicians who are board-certified or board-eligible.
Global Stem Cells Group and Regenestem will remain committed to the highest of standards in service and technology, expert and compassionate care.
For more information, please contact Benito Novas at 305-560-5337 (Bnovas(at)stemcellsgroup.com) or Ricardo De Cubas at 305-224-1858 (rdecubas(at)regenestem.com).
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group's corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG's six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
About Regenestem and Regenestem Network:
Regenestem is an international medical practice association committed to researching and producing comprehensive stem cell treatments for patients worldwide. Having assembled a highly qualified staff of medical specialists—professionals trained in the latest cutting-edge techniques in cellular medicine—Regenestem continues to be a leader in delivering the latest protocols in the adult stem cell arena.
The largest membership network of regenerative medicine clinics in the world, Regenestem Network members provide cutting-edge care with the latest advancements in cellular therapies to patients worldwide.
The Regenestem Network mission is to make the promise of stem cell medicine a reality for patients around the world. The program consists of a rapidly expanding network of physicians who are assigned exclusive territory within their country and specialty. Each physician is trained by Regenestem’s professional staff.